Current highlights

  1. Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder

    Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder

    Abstract Full Text Full Text PDF (0,9 MB) Patient Summary
  2. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses

    Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses

    Abstract Full Text Full Text PDF (1,4 MB) Patient Summary
  3. Efficacy Outcomes by Baseline Prostate-specific Antigen Quartile in the AFFIRM Trial

    Efficacy Outcomes by Baseline Prostate-specific Antigen Quartile in the AFFIRM Trial

    Abstract Full Text Full Text PDF (515 KB) Patient Summary
  4. European Urology: Serving Our Readership Through Systematic Peer Review, Use of Reporting Standards, and Encouragement of Postpublication Review

    European Urology: Serving Our Readership Through Systematic Peer Review, Use of Reporting Standards, and Encouragement of Postpublication Review

    Abstract Full Text Full Text PDF (858 KB)
  5. Diagnosing the Pathophysiologic Mechanisms of Nocturnal Polyuria

    Diagnosing the Pathophysiologic Mechanisms of Nocturnal Polyuria

    Abstract Full Text Full Text PDF (764 KB) Patient Summary

Hot off the press

  1. Systematic Review and Meta-analysis of Factors Determining Change to Radical Treatment in Active Surveillance for Localized Prostate Cancer

    Systematic Review and Meta-analysis of Factors Determining Change to Radical Treatment in Active Surveillance for Localized Prostate Cancer

    Abstract Full Text Full Text PDF (0,9 MB) Patient Summary
    Corrected
  2. Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    Abstract Full Text Full Text PDF (530 KB) Patient Summary
    Corrected
  3. Impact of Baseline Corticosteroids on Survival and Steroid Androgens in Metastatic Castration-resistant Prostate Cancer: Exploratory Analysis from COU-AA-301

    Impact of Baseline Corticosteroids on Survival and Steroid Androgens in Metastatic Castration-resistant Prostate Cancer: Exploratory Analysis from COU-AA-301

    Abstract Full Text Full Text PDF (424 KB) Patient Summary
    Corrected
  4. Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models

    Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models

    Abstract Full Text Full Text PDF (1,3 MB) Patient Summary
    Corrected